Technology Convergence Report 2025
Page 29 of 60 · WEF_Technology_Convergence_Report_2025.pdf
Convergence transformation
The combination patterns in engineering
biology demonstrate how biological and digital
systems are becoming increasingly intertwined,
creating transformative capabilities that extend
far beyond traditional applications. These
combinations, empowered by advancements in
AI, have significantly accelerated the value chain
transformation into new product categories and
can now address previously unsolvable challenges.
Traditionally, engineering biology technologies
operated mainly in the healthcare industry, with long
go-to-market strategies due to extensive research
and development as well as certifications. Now,
with recent breakthroughs in AI, it is transforming
the value chain by enabling engineering biology to
learn from data, recognize patterns, and be much
more precise and tailored to complex environments,
creating new applications in consumer goods,
energy and the food industry.As engineering biology technologies continue
to mature, investors remain optimistic about
the potential of start-ups in this field.17 Venture
investment appears to have stabilized at levels
seen prior to the COVID-19 pandemic-era spike.
However, due to the inherent technological
complexity, high capital requirements and extended
go-to-market timelines, capturing investor interest
remains challenging. As narratives increasingly shift
towards planetary outcomes, application areas
beyond healthcare are expected to become more
attractive for investment.
The cross-cutting and technologically complex
nature of the engineering biology technology poses
significant barriers in devising comprehensive
yet efficient policy and regulatory frameworks.
Early policy decisions are especially influential, as
they shape the speed and scale at which bio-
based, tech-driven approaches can be adopted.
Momentum varies widely across regions, influenced
by national priorities, regulatory readiness and the
ability to integrate bio-based innovation into broader
industrial strategies.
CASE STUDY 6
The Commonwealth Scientific and Industrial Research Organisation (CSIRO)
The Commonwealth Scientific and Industrial Research
Organisation (CSIRO) has embraced application and
development of AI for scientific research, incorporating
advanced ML capabilities directly into its scientific workflows.
By integrating AI specialists into multidisciplinary research
teams, CSIRO enhances its ability to achieve precise
molecular design, optimize complex biological processes
and perform real-time experimentation across various
scientific disciplines.
These initiatives accelerate research, enabling rapid
simulation and iterative development. They reinforce CSIRO’s
leadership in engineering biology and enhance its capacity
to address complex challenges across healthcare, agriculture
and energy sectors. This approach creates a continuous
feedback loop of innovation, significantly amplifying CSIRO’s
cross-industry impact. AI for plant protein
AI-driven biological modelling to optimize crop resilience,
improve yields and reduce environmental impact. By predicting
yield, taste and functional properties of different plant proteins,
they accelerate new ingredient and product development,
reducing time-to-market while promoting innovation.
Precision fermentation for food innovation
CSIRO uses precision fermentation to engineer
microorganisms that produce animal-free proteins and fats.
This enables the development of lactose-free, sustainable
dairy alternatives, meeting growing consumer demand,
unlocking potential new market segments.
Technology Convergence Report
29
Ask AI what this page says about a topic: